ArticleMolecular medicine (Cambridge, Mass.)2020

Subunits of ARID1 serve as novel biomarkers for the sensitivity to immune checkpoint inhibitors and prognosis of advanced non-small cell lung cancer.

Dantong Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.